Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1171382 | 0.82 | ALDH1A1 (0.39) | CYP3A4ALDH1A1TDP1LMNATSHR | |
| SCHEMBL29619785 | 0.80 | ALDH1A1 (0.41) | CYP3A4ALDH1A1TDP1LMNATSHR | |
| SCHEMBL225537 | 0.80 | ALDH1A1 (0.41) | CYP3A4ALDH1A1TDP1LMNATSHR | |
| SCHEMBL11075172 | 0.79 | MEN1 (0.32) | CYP3A4MEN1ALOX15KMT2A | |
| SCHEMBL569847 | 0.79 | TDP1 (0.32) | CYP3A4TDP1MEN1ALOX15KMT2A | |
| SCHEMBL27959568 | 0.79 | MEN1 (0.35) | CYP3A4MEN1ALOX15KMT2ATSHR | |
| SCHEMBL11075175 | 0.79 | MEN1 (0.32) | CYP3A4MEN1ALOX15KMT2A | |
| SCHEMBL17710673 | 0.79 | MEN1 (0.32) | CYP3A4MEN1ALOX15KMT2A | |
| SCHEMBL19812429 | 0.79 | CYP3A4 (0.36) | CYP3A4ALDH1A1TDP1LMNAMEN1 | |
| SCHEMBL158257 | 0.78 | GAA (0.37) | CYP3A4ALDH1A1TDP1LMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4662194-A1 | NEW METHOD FOR OZONOLYSIS AND REDUCTIVE QUENCHING OF OZONIDES | P2 Science, Inc. (US) | 2025-12-17 | — | — | EP | claimed |
| WO-2024167957-A1 | NEW METHOD FOR OZONOLYSIS AND REDUCTIVE QUENCHING OF OZONIDES | P2 SCIENCE, INC. (US) | 2024-08-15 | — | — | WO | claimed |
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| EP-4662194-A1 | NEW METHOD FOR OZONOLYSIS AND REDUCTIVE QUENCHING OF OZONIDES | P2 Science, Inc. (US) | 2025-12-17 | — | — | EP | disclosed |
| CN-119798050-A | Method for synthesizing santalol ether from methoxy citronellene | 万华化学集团股份有限公司 | 2025-04-11 | — | — | CN | disclosed |
| WO-2024167957-A1 | NEW METHOD FOR OZONOLYSIS AND REDUCTIVE QUENCHING OF OZONIDES | P2 SCIENCE, INC. (US) | 2024-08-15 | — | — | WO | disclosed |
| EP-3927688-B1 | PROCESS FOR PERHYDROLYSIS OF ALIPHATIC EPOXIDES | DEMETA (FR) | 2024-01-31 | — | — | EP | disclosed |
| US-11512050-B2 | Process for perhydrolysis of aliphatic epoxides | DEMETA (FR) | 2022-11-29 | — | — | US | disclosed |
| US-20220169601-A1 | PROCESS FOR PERHYDROLYSIS OF ALIPHATIC EPOXIDES | UNIVERSITE DE RENNES (FR) | 2022-06-02 | — | — | US | disclosed |
| EP-3927688-A1 | PROCESS FOR PERHYDROLYSIS OF ALIPHATIC EPOXIDES | Demeta (FR) | 2021-12-29 | — | — | EP | disclosed |
| CN-113614067-A | Process for perhydrolysis of aliphatic epoxides | 德美特 | 2021-11-05 | — | — | CN | disclosed |
| US-20160332952-A1 | TERPENE-DERIVED ACIDS AND ESTERS AND METHODS FOR PREPARING AND USING SAME | P2 SCIENCE, INC. | 2016-11-17 | — | — | US | disclosed |
| WO-2015191706-A1 | TERPENE-DERIVED COMPOUNDS AND METHODS FOR PREPARING AND USING SAME | P2 SCIENCE, INC. (US) | 2015-12-17 | — | — | WO | disclosed |
| WO-2015106293-A1 | TERPENE-DERIVED ACIDS AND ESTERS AND METHODS FOR PREPARING AND USING SAME | P2 SCIENCE, INC. (US) | 2015-07-16 | — | — | WO | disclosed |
| US-20140357547-A1 | PROCESS FOR THE PREPARATION OF METHOXYMELONAL | GIVAUDAN S.A. (CH) | 2014-12-04 | — | — | US | disclosed |
| US-20140357547-A1 | PROCESS FOR THE PREPARATION OF METHOXYMELONAL | GIVAUDAN S.A. (CH) | 2014-12-04 | — | — | US | disclosed |
| WO-2013053102-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2013-04-18 | — | — | WO | disclosed |
| EP-0127672-A1 | PROCESS FOR PREPARATION OF ARYLTERPENOID INSECT MATURATION INHIBITORS | SCM CORPORATION (US) | 1984-12-12 | — | — | EP | disclosed |
| US-4484007-A | Process for preparation of arylterpenoid insect maturation inhibitors | SCM CORPORATION (US) | 1984-11-20 | — | — | US | disclosed |
| WO-1984002337-A1 | PROCESS FOR PREPARATION OF ARYLTERPENOID INSECT MATURATION INHIBITORS | SCM CORP (US) | 1984-06-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140357547-A1 | PROCESS FOR THE PREPARATION OF METHOXYMELONAL | MSMO1, CYP17A1, CYP51A1 | CYP3A4 74/4885ALDH1A1 736/4885TDP1 2155/4885 |
| US-20160332952-A1 | TERPENE-DERIVED ACIDS AND ESTERS AND METHODS FOR PREPARING AND USING SAME | GGPS1, CYP51A1, LSS | CYP3A4 89/4885ALDH1A1 761/4885TDP1 3561/4885 |
| US-20220169601-A1 | PROCESS FOR PERHYDROLYSIS OF ALIPHATIC EPOXIDES | HAO2, HPD, HOGA1 | CYP3A4 637/4885ALDH1A1 350/4885TDP1 1326/4885 |
| US-11512050-B2 | Process for perhydrolysis of aliphatic epoxides | HAO2, HPD, HOGA1 | CYP3A4 637/4885ALDH1A1 350/4885TDP1 1326/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.